HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vatche Tchekmedyian Selected Research

Adenoid Cystic Carcinoma (Cylindroma)

12/2023Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial.
1/2019Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vatche Tchekmedyian Research Topics

Disease

8Neoplasms (Cancer)
12/2023 - 05/2017
3Thyroid Neoplasms (Thyroid Cancer)
01/2022 - 01/2019
2Adenoid Cystic Carcinoma (Cylindroma)
12/2023 - 01/2019
1Skin Neoplasms (Skin Cancer)
01/2024
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2024
1Salivary Gland Neoplasms (Salivary Gland Cancer)
12/2023
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
04/2022
1Oropharyngeal Neoplasms
01/2021
1Papillary Thyroid Cancer
01/2021
1Neoplasm Metastasis (Metastasis)
01/2021
1Disease Progression
01/2021
1Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2017
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2017
1Hodgkin Disease (Hodgkin's Disease)
05/2017
1Lymphoma (Lymphomas)
05/2017
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
05/2017
1Coma (Comas)
01/2017
1Hyperammonemia
01/2017

Drug/Important Bio-Agent (IBA)

2VemurafenibIBA
01/2022 - 01/2019
1cemiplimabIBA
01/2024
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
12/2023
1IpilimumabIBA
12/2023
1RNA (Ribonucleic Acid)IBA
12/2023
1NivolumabIBA
12/2023
1Cefepime (Maxipime)FDA LinkGeneric
04/2022
1Iodine-124IBA
01/2022
1Monoclonal AntibodiesIBA
01/2022
1IodineIBA
01/2022
1Sucrose (Saccharose)IBA
01/2022
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2022
1Mitogen-Activated Protein KinasesIBA
01/2022
1Thyrotropin AlfaFDA LinkGeneric
01/2022
1Androgen Receptors (Androgen Receptor)IBA
10/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1Transcription Factors (Transcription Factor)IBA
01/2021
1Cisplatin (Platino)FDA LinkGeneric
01/2021
1ChromatinIBA
01/2021
1lenvatinibIBA
01/2019
1ThyroglobulinFDA Link
01/2019
1phenylacetic acid (phenylacetate)FDA Link
01/2017
1Glutamic Acid (Glutamate)FDA Link
01/2017
1AmmoniaIBA
01/2017
1Sodium BenzoateFDA Link
01/2017
1Biomarkers (Surrogate Marker)IBA
01/2017
1Glutamine (L-Glutamine)FDA Link
01/2017

Therapy/Procedure

6Therapeutics
01/2022 - 01/2017
1Immunotherapy
01/2024
1Radiotherapy
01/2021
1Stem Cell Transplantation
05/2017
1Transplantation
05/2017
1Autologous Transplantation
05/2017
1Gastric Bypass (Roux-en-Y Gastric Bypass)
01/2017